Technology plays a critical role in helping patients, and the clinicians and institutions they trust, make every moment matter in the fight against cancer.

With this blog, we aim to explore the challenges faced by the clinical trial and cancer registry communities and bring light to the innovative solutions that are transforming the landscape.

Achieving accrual targets for oncology clinical trials has always been a significant challenge, but more recently, it seems to be...

What can you do in a second or two of time? Most of us do not give it much thought, but in the right context, you may be...

At Inspirata, we believe that using technology such as Artificial Intelligence (AI) and Natural Language Processing (NLP) to...

In a prior post, I endeavoured to introduce the importance of patient and public involvement (PPI) in the delivery of cancer...

The instant my haematologist mentioned the word cancer, I stopped listening. Not purposely of course, I was in shock. Rather than...

This week, April 5th – 9th, 2021, marks the 25th annual National Cancer Registrars Week (NCRW). This year’s theme, “Cancer...

At the end of 2020, I was delighted to take up the opportunity to join Inspirata as its business unit lead for cancer...

The astonishing success of artificial intelligence (AI) over the past few years in solving complex recognition problems has...

During a recent virtual fireside chat, I met with industry experts Courtney Hudson, President and Founder of Carebox; and Cyntha...

Back in May 2020, at the early stage of the COVID-19 pandemic, the Inspirata team was very much focused on supporting the...

Passing information to the next generation is critically important.

Ten years ago, when my son was born, I had an epiphany.  The...

We would like to hear from anyone willing to share their ideas. For those who are feeling adventurous and creative, we would like...